Coronavirus | EU drug regulator evaluating Pfizer vaccine for youngsters in 12-15 age group
The Hindu
European Medicines Agency evaluating request by Pfizer Inc and BioNTech
The European Union's drug regulator said Monday it has begun evaluating aInc and BioNTech to extend approval of their coronavirus vaccine to include children ranging in age from 12 to 15. The European Medicines Agency's human medicines committee will carry out an accelerated assessment of data submitted by Pfizer and BioNTech and is expected to reach a decision in June, unless it requires extra information, the agency said. In a statement Friday, the two pharmaceuticals said their request is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective. The children will continue to be monitored for longer-term protection and safety for another two years.More Related News

The draft policy for “Responsible Digital Use Among Students”, released on Monday by the Department of Health and Family Welfare, has recommended that parents set structured routines with clear screen-time rules and prioritise privacy, safety, and open conversation with children on digital well-being.












